Your Location:
Home >
Browse articles >
Effect Difference and Mechanisms of Zishenwan Against Chronic Prostatitis Before and After Salt-processing of Anemarrhenae Rhizoma and Phellodendri Chinensis Cortex by Integrating Network Pharmacology and Metabolomics
Effect Difference and Mechanisms of Zishenwan Against Chronic Prostatitis Before and After Salt-processing of Anemarrhenae Rhizoma and Phellodendri Chinensis Cortex by Integrating Network Pharmacology and Metabolomics
Enhanced Publication- “The research team has revealed the mechanism of action of salt roasted Zishen Wan in treating chronic prostatitis. "After salt roasting, the content of berberine, berberine and other components in Zishen Wan increases, which may enhance the therapeutic effect on CP by inhibiting signaling pathways such as PI3K/Akt and MAPK, as well as multi-target regulation of metabolic pathways such as tryptophan, arginine and pantothenic acid." This provides new evidence for the study of enhancing the efficacy of traditional Chinese medicine processing.”
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 32, Issue 13, Pages: 177-187(2026)
DOI: 10.13422/j.cnki.syfjx.20260268
Revised:2026-03-08 ,
Accepted:18 March 2026
Scan QR Code
AI Introduction
Full Text(HTML)
Figs( 1 ) Tabs( 6 )
References
Publication Info
Metrics
211
Views
105
Downloads
0
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Mechanism of Huoxin Pills in Stabilizing Atherosclerotic Vulnerable Plaque Based on Network Pharmacology and Metabolomics
Xuefu Zhuyutang Ameliorates Metabolic-associated Fatty Liver Disease via AMPK Signaling Pathway
Bioinformatics Reveals Mechanism of Zuoguiwan in Treating Polycystic Ovary Syndrome
Exploration of Material Basis of "Clearing Excessive Fire of Liver-gallbladder" of Bile-processed Coptidis Rhizoma Based on UPLC-Q-TOF/MS Metabolomics and Molecular Docking Technology
Pinelliae Rhizoma and Its Prescription Compatibility for Depression Treatment: A Review
Related Author
XIANG Jiao
LUO Jieying
LIAO Daiyuan
LI Fulai
YI Rui
LIANG Yong
MO Zunhui
LIU Dongyan
Related Institution
School of Chinese Materia Medica,Guangzhou University of Chinese Medicine
Baiyunshan Pharmaceutical General Factory, Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd.
Guangzhou Caizhilin Pharmaceutical Co. Ltd.
School of Integrated Chinese and Western Medicine, Hebei University of Chinese Medicine
The Third Hospital of Hebei Medical University


